EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Mitochondrial Quality Control for the Treatment of Triple-Negative Breast Cancer: From Molecular Mechanisms to Precision Therapy

Wanjuan Pei iD, Ling Dai, Mingxiao Li, Sihui Cao, Yili Xiao, Yan Yang, Minghao Ma, Minjie Deng iD, Yang Mo, Mi Liu iD

Biomolecules · 05.07.2025 · 15 (7) · 970

DOI: 10.3390/biom15070970 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 05.07.2025. Verfasst von Wanjuan Pei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Hunan University of Chinese Medicine, Changsha 410208, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Mitochondria, Precision Medicine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the science and technology innovation Program of Hunan Province, the State Administration of Traditional Chinese Medicine 2022 Youth Qihuang Scholars Training Program, the Acupuncture Bioinformation and Smart Wellness Innovation and Entrepreneurship Education Center of Hunan University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the leading threat to the health of women, with a rising global incidence linked to social and psychological factors. Among its subtypes, triple-negative breast cancer (TNBC), which lacks estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, is highly heterogeneous with early metastasis and a poor prognosis, making it the most challenging subtype. Mounting evidence shows that the mitochondrial quality control (MQC) system is vital for maintaining cellular homeostasis. Dysfunction of the MQC is tied to tumor cell invasiveness, metastasis, and chemoresistance. This paper comprehensively reviews the molecular link between MQC and TNBC development. We focused on how abnormal MQC affects TNBC progression by influencing chemoresistance, immune evasion, metastasis, and cancer stemness. On the basis of current studies, new TNBC treatment strategies targeting key MQC nodes have been proposed. These findings increase the understanding of TNBC pathogenesis and offer a theoretical basis for overcoming treatment challenges, providing new research angles and intervention targets for effective precision therapy for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsMitochondriaPrecision MedicineHumansFemaleDrug Resistance, NeoplasmAnimals

Stichwörter der Autor:innen

TNBCimmune evasionmaintenance of stemnessmetabolic reprogrammingmitochondrial quality control

Autor:innen und Institutionen

  • Medical College, Hunan University of Chinese Medicine, Changsha 410208, China.
  • College of Acupuncture and Moxibustion, Hunan University of Chinese Medicine, Changsha 410208, China.

ORCID-Profile: Wanjuan Pei, Minjie Deng, Mi Liu

Förderung

  • the science and technology innovation Program of Hunan Province
  • the State Administration of Traditional Chinese Medicine 2022 Youth Qihuang Scholars Training Program
  • the Acupuncture Bioinformation and Smart Wellness Innovation and Entrepreneurship Education Center of Hunan University of Chinese Medicine
  • the 2024 Provincial College Students Innovation and Entrepreneurship Training Program Project at Hunan University of Chinese Medicine
  • science and technology innovation Program of Hunan Province
  • State Administration of Traditional Chinese Medicine 2022 Youth Qihuang Scholars Training Program
  • Acupuncture Bioinformation and Smart Wellness Innovation and Entrepreneurship Education Center of Hunan University of Chinese Medicine
  • 2024 Provincial College Students Innovation and Entrepreneurship Training Program Project

Zitieren

APA

Pei, W., Dai, L., Li, M., Cao, S., Xiao, Y., Yang, Y., Ma, M., Deng, M., Mo, Y., & Liu, M. (2025). Targeting Mitochondrial Quality Control for the Treatment of Triple-Negative Breast Cancer: From Molecular Mechanisms to Precision Therapy. Biomolecules, 15(7), 970. https://doi.org/10.3390/biom15070970

Vancouver

Pei W, Dai L, Li M, Cao S, Xiao Y, Yang Y, et al. Targeting Mitochondrial Quality Control for the Treatment of Triple-Negative Breast Cancer: From Molecular Mechanisms to Precision Therapy. Biomolecules. 2025;15(7):970. doi:10.3390/biom15070970

BibTeX
@article{Pei2025,
  author = {Pei, Wanjuan and Dai, Ling and Li, Mingxiao and Cao, Sihui and Xiao, Yili and Yang, Yan and Ma, Minghao and Deng, Minjie and Mo, Yang and Liu, Mi},
  title = {Targeting Mitochondrial Quality Control for the Treatment of Triple-Negative Breast Cancer: From Molecular Mechanisms to Precision Therapy},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {970},
  doi = {10.3390/biom15070970}
}
Kostenlos starten →